CBLI : Summary for Cleveland BioLabs, Inc. - Yahoo Finance

U.S. Markets open in 6 hrs 15 mins

Cleveland BioLabs, Inc. (CBLI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.55+0.09 (+6.11%)
At close: 4:00PM EDT
People also watch
CYCCCLSNAVEOABIOCYTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.46
Open1.48
Bid0.00 x
Ask1.67 x 1000
Day's Range1.46 - 1.67
52 Week Range1.22 - 3.30
Volume79,398
Avg. Volume46,223
Market Cap17.03M
Beta-1.37
PE Ratio (TTM)-6.40
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube6 days ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Sanofi Sponsored ADR, Amgen Inc., Eli Lilly and Company and GlaxoSmithKline ... Read more (Read more...)

  • Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube8 days ago

    Cleveland BioLabs, Inc. :CBLI-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Cleveland BioLabs, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Cleveland BioLabs, Inc. – OPKO Health, Inc., Novartis AG Sponsored ADR, Bristol-Myers Squibb Company, Cascadian Therapeutics Inc., Sanofi Sponsored ADR, Amgen Inc., Eli Lilly and Company and GlaxoSmithKline ... Read more (Read more...)

  • Marketwired28 days ago

    Cleveland BioLabs Reports 2016 Financial Results and Development Progress

    Cleveland BioLabs, Inc. today reported financial results and development progress for the fourth quarter and year ended December 31, 2016.